Chemistry, manufacturing and controls information is some of the most reused content in a regulatory dossier. The same specification, the same process description and the same stability data appear in submissions to many regions, in variations, in annual reports and in responses to questions. Most companies still manage it as documents. That is starting to change.
The problem with documents
When CMC information lives only in documents, every reuse is a copy. A specification changes, and somebody has to find every submission, every regional version and every pending variation that contains it. That search is slow, depends on people who know where things are, and occasionally misses something. A mismatch between what is registered in two markets is a finding waiting to happen.
What structured CMC means
Structured CMC means managing the information as data: a specification is a set of tests with methods and acceptance criteria, linked to the product and the markets where it is registered. Documents are generated from the data, rather than the data being trapped in documents.
Regulators are moving in the same direction. ICH is revising the M4Q guideline on the quality section of the dossier, partly to support more structured submissions, and the FDA has been working on structured quality data standards for several years. Neither has reached the point where structured submission is required, but the direction is clear.
The practical benefits now
You do not have to wait for regulators to benefit. Structured CMC data answers questions that are slow to answer today: where is this parameter registered, which markets would this change affect, are our registrations consistent with each other and with what we actually do? It also makes ICH Q12 lifecycle management more practical, because established conditions become data you can query.
Where to begin
Not with everything. Start with the content that changes most and is reused most, usually specifications and the list of registered sites, suppliers and methods. Get that right for a small set of products, and connect it to the change control process so that a change prompts the question of which registrations it touches.
Who owns the data
Structured data needs owners in a way documents do not. A document has an author and an approver. A data element such as a specification limit may be used in a dozen documents, by several teams, in several markets. Someone has to own its accuracy, approve changes and know where it is used.
Most companies find that ownership sits naturally with the function that controls the underlying fact: quality control for specifications, manufacturing for process parameters, regulatory for registration status. The hard part is agreeing it and writing it down before the data is in use.
What to watch out for
Structuring content is a data migration, and it carries the same risks: extraction errors, missing context and records that look complete but are not. Verify the structured data against the registered documents before relying on it, and keep the link between each data point and the document it came from. Our RIM implementation work and CMC guide cover the wider context. If you want help scoping a first step, get in touch.
Where to go next
Explore GxP Copilot for AI-native validation, TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.